Market Cap

Galmed Pharmaceuticals Ltd. Market Capitalization:

$17,978

USD as of Jan. 1, 2024

business Galmed Pharmaceuticals Ltd. Company Profile

Galmed Pharmaceuticals Ltd. Main Stock Listing

NASDAQ: GLMD

Market Capitalization History of Galmed Pharmaceuticals Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Galmed Pharmaceuticals Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $17,978 -90.51%
Jan. 1, 2023 $189,353 -53.64%
Jan. 1, 2022 $408,458 -56.22%
Jan. 1, 2021 $932,898 -28.57%
Jan. 1, 2020 $1.3 M -34.51%
Jan. 1, 2019 $2.0 M -20.74%
Jan. 1, 2018 $2.5 M 144.61%
Jan. 1, 2017 $1.0 M -34.72%
Jan. 1, 2016 $1.6 M -4.14%
Jan. 1, 2015 $1.6 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Galmed Pharmaceuticals Ltd. Categories

Israel languages Healthcare languages Biotechnology
Israel Healthcare Israel Biotechnology

Stocks & Indices

Galmed Pharmaceuticals Ltd. has the following listings and related stock indices.


Stock: NASDAQ: GLMD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.